seed
Stage
2
Investors
About
Obulytix develops next-generation enzyme-based antibiotics inspired by nature; it is presented as a spin-out from Universiteit Gent (Ghent University).
Explore Obulytix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.